J&J to buy Santa Clara-based Shockwave for $13 billion in medical device play

J&J has been rapidly building its portfolio in both medical technology and drug development to help prepare for the impending loss of exclusivity for Stelara, its top-selling drug for psoriasis, in the US next year.

Related Keywords

Boston ,Massachusetts ,United States ,New York ,Mizuho Jared Holz ,Gerry Smith ,John Lauerman Bloomberg ,Abiomed ,Shockwave Medical Inc ,Jpmorgan Securities ,Ambrx Biopharma Inc ,Boston Scientific Corp ,Johnson ,John Lauerman ,Shockwave Medical ,Santa Clara Based Shockwave ,Jared Holz ,Boston Scientific ,Ambrx Biopharma ,Perella Weinberg Partners ,